INNOHEALTH USA Winning Team
© K. Dobberke for Fraunhofer ISC

Winning team

Tandem project MAXSAM becomes one of the winning teams of the InnoHealth USA campaign with OZA Analytic GmbH

more info
Corona Drug testing
© K. Dobberke / pixabay

Research against the corona virus

The Fraunhofer ISC with its Translational Center for Regenerative Therapies is working together with virologists from the University of Würzburg to combat the virus: with rapid tests of potential active substances against SARS-CoV-2.

more info

Lab Automation and Bioreactor Technologies

The incubator and bioreactor systems developed at TLC-RT have a modular structure and can be adjusted to a wide variety of culture conditions.

more info

Biomaterials

The TLC-RT develops synthetic as well as bio-logically based materials, e. g. (μ- and nano-) particles, fibers, coatings for regenerative medicine, tissue engineering and diagnostics. One of the core tasks is to cover the entire value chain, starting from R&D-tasks over process up-scaling, pre-clinic evaluation to the clinical phases.

more info

Clinical Development

The production of novel drugs and medical devices is subject to high quality requirements. By fulfilling current regulatory guidelines, the TLC-RT ensures the highest level of patient safety for these new, innovative therapies.

more info

Test Systems and 3D Tissue Models

3D tissue models includes model systems of healthy and diseased organs to study pathogenic mechanisms and to test and evaluate new drugs. Picture shows a full skin model.

more info

Fraunhofer Translational Center Regenerative Therapies TLC-RT

more info

Fraunhofer Translational Center Regenerative Therapies TLC-RT

The Fraunhofer Translational Center Regenerative Therapies TLC-RT develops new cell based tissue models and test systems, scalable manufacture processes, prototypes and biological vascularized implants. Therefore, besides accelerating cost efficient drug development, TLC-RT contributes to promoting the 3R principles.

Read more ...

 

Award winner at the Pitch Awards 2021

Sanjana Mathew won the 2nd place at the Pitch Awards 2021 of the stem cell network NRW.


Sanjana Mathew, PhD student in Dr. Antje Appelt-Menzel's team, used a bioreactor with dynamic flow, which enables the quality control of the barrier of blood-brain barrier models through online impedance measurement.

 

2nd place at the Hugo-Junkers-Preis 2020

As part of the research consortium HiPSTAR, Dr. Appelt-Menzel won the 2nd place at the Hugo-Junkers-Preis 2020 in the field of basic research.

The research team examines the dementia Alzheimer's desease and the role of the blood-brain barrier in its development and treatment. Novel therapies can be tested without animal experiments using in vitro models derived from patient-specific stem cells.

 

ARABLAB 2021

Together with the Center of Device Development CeDeD, we will be presenting our technologies in Hall 4 at Stand 510: an INCUBATOR system for tissue engineering and AQUAJUST® CAM for adjusting laboratory glasses.

 

Winning Team

Tandem project MAXSAM becomes one of the winning teams of the InnoHealth USA campaign with OZA Analytic GmbH

 

Research against the corona virus

Tissue models for rapid drug testing

 

Partner for EU projects

Fraunhofer ISC has an excellent record of accomplishments in European collaboration and can build on a large international network of research partners from industry as well as research.

Fields of Activity and Teaching

 

Biomaterials

  • Regenerative Biomaterials
  • In vitro and in vivo diagnostics
  • Drug Delivery
  • Future Technologies
 

Lab Automation and Bioreactor Technologies

 

In vitro Test Systems

  • Standardized in vitro test systems
  • Disease models
  • hiPSC technologies
 

Preclinical and Clinical Development

  • Implants / GMP
  • Preclinical / GLP
 

Chair of Tissue
Engineering and
Regenerative Medicine

  • Development of supporting structures
  • Cell culture techniques
 

Contact or callback?

 

Contact us today without any
obligation!

 

Project TheraVision – Innovative therapy against cancer

In the "TheraVision" project, five Fraunhofer Institutes have set themselves the goal of establishing a widely applicable platform technology for an innovative, sustainable cancer therapy that combines cancer-killing viruses and immunotherapy. The activation of the immune system against the degenerated tumor cells is a novel promising therapeutic approach.

News and Events

15.11.2021

ARABLAB 2021

At ARABLAB 2021, Fraunhofer ISC will present technologies from the Center of Device Development CeDeD and the Translational Center for Regenerative Therapies TLC-RT in Hall 4, Booth 510: AQUAJUST® CAM for the adjustment of laboratory glasses and an INCUBATOR system for tissue engineering.
Read more

19.11.2020

New test procedure to replace worldwide standard animal testing - project launched

The ImAi project, funded by the Federal Ministry of Education and Research, is intended to create an animal-free replacement for the Draize test on rabbits used worldwide to assess the eye irritancy potential of chemicals. The new test is based on tissue models of the cornea cultivated in the laboratory. At the end of the project, a new standard procedure should be available for use worldwide.
Read more

26.10.2020

Fraunhofer Solution Days

As part of the project “Go Beyond 4.0”, Fraunhofer ISC is participating in the digital Fraunhofer event, the Solution Days, on October 26, 2020. You can look forward to the latest technology highlights, workshops and live chats with our experts. We are looking forward to your visit on our digital booth.
Read more
 

Project APRONA

Flexible robot-based platform for automated production of nanoparticles.

Your local contact

Marco Metzger

Contact Press / Media

PD Dr. Marco Metzger

Director TLC-RT

Fraunhofer Translational Center Regenerative Therapies TLC-RT
Röntgenring 11
97070 Würzburg, Germany

Phone +49 931 3186686

Oliver Pullig

Contact Press / Media

PD Dr. Oliver Pullig

Deputy Director of TLC-RT / Head of Clinical Development

Translational Center Regenerative Therapies TLC-RT
Röntgenring 11
97070 Würzburg, Germany

Phone +49 931 31-83748